Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Other Working Capital Changes (2016 - 2025)

Lifecore Biomedical, Inc. \De\ (LFCR) has 16 years of Other Working Capital Changes data on record, last reported at -$1.6 million in Q2 2025.

  • For Q2 2025, Other Working Capital Changes fell 85.52% year-over-year to -$1.6 million; the TTM value through May 2025 reached -$378000.0, up 86.76%, while the annual FY2025 figure was -$378000.0, 86.76% up from the prior year.
  • Other Working Capital Changes reached -$1.6 million in Q2 2025 per LFCR's latest filing, down from $97000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $2.4 million in Q3 2023 and bottomed at -$4.4 million in Q4 2023.
  • Average Other Working Capital Changes over 5 years is -$132333.3, with a median of $91500.0 recorded in 2021.
  • Peak YoY movement for Other Working Capital Changes: surged 759.3% in 2022, then plummeted 31678.57% in 2023.
  • A 5-year view of Other Working Capital Changes shows it stood at -$56000.0 in 2021, then surged by 75.0% to -$14000.0 in 2022, then tumbled by 31678.57% to -$4.4 million in 2023, then soared by 120.79% to $925000.0 in 2024, then crashed by 274.49% to -$1.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Working Capital Changes were -$1.6 million in Q2 2025, $97000.0 in Q1 2025, and $925000.0 in Q4 2024.